Roche builds “best research center in the world”
The pharmaceutical giant Roche has officially started building its new research center in Basel. Around 1,800 researchers should be able to work there by the end of 2023.
This is what Roche's new research center will look like (Visualization: Roche)
Roche has laid the foundation for its new research center (pRED Innovation Center) in Basel. A state-of-the-art laboratory and office environment will be completed by the end of 2023 at the company headquarters, providing space for about 1,800 researchers.
According to Roche’s own information, it is investing CHF 3 billion in development at the Basel site overall. From this, around CHF 1.2 billion will be put towards the new research center alone, which will comprise four new buildings. This investment is said to be a clear commitment to Switzerland as a location for research and business. Jürg Erismann, Head of the Basel/Kaiseraugst site at Roche, is quoted in an article by SRF, saying: “We are building the best research center in the world.” In the press release from Roche, he adds that the work environment being created can adapt to the changing requirements of the research division and digitization.
Sustainability is particularly important in constructing the new buildings; for instance, recycled concrete is being used to create the shell. Solar power systems will also be installed on the roofs of two buildings.
Share this article
You might also be interested in
A research project is investigating the improvement in the condition of patients who have been hospitalized due to COVID-19. docdok.health based in Basel is contributing the smartphone app for the project.Read More
The Allschwil-based pharmaceutical company Idorsia receives a payment of 45 million US dollars as part of an agreement with Neurocrine Biosciences and shall also be entitled to claim milestone payments in future. Neurocrine has exercised a licensing option for a drug developed by Idorsia to treat epilepsy..Read More
Roche has received Emergency Use Authorization in the USA for an antibody test in connection with the novel coronavirus. The tests are already being distributed around the world. In May, production capacities are to already be scaled up to the high double-digit million area.Read More
Basel is valued as a location for company headquarters. In a rating from the fDi Intelligence platform of the Financial Times, Basel achieves eighth place in Europe. No other Swiss city does better.Read More
The investment and innovation promotion agency Basel Area Business & Innovation, previously known as BaselArea.swiss, can look back on a successful year in 2019. In this regard, positive developments in the healthtech sector and in Switzerland Innovation Park Basel Area stand out.Read More
The University Hospital Basel is the first Swiss hospital to have treated two Covid-19 patients with the plasma from a patient who has recovered from the virus, which means that they are receiving the appropriate antibodies. This method is a potential therapeutic option.Read More
The Basel-based Botnar Research Center for Child Health is providing capital in the amount of 15 million Swiss francs to its four partner institutions. In this way, the University of Basel should be in a position to advance research into dealing with the coronavirus outbreak.Read More